Credit Suisse Group initiated coverage on shares of Core Laboratories (NYSE:CLB) in a report published on Thursday. The brokerage issued an outperform rating and a $107.94 price objective on the oil and gas company’s stock.
Several other equities analysts have also recently commented on the stock. Piper Jaffray Companies assumed coverage on shares of Core Laboratories in a research report on Tuesday. They set a neutral rating and a $96.00 target price on the stock. Zacks Investment Research raised shares of Core Laboratories from a sell rating to a hold rating in a research report on Tuesday, March 6th. ValuEngine cut shares of Core Laboratories from a hold rating to a sell rating in a research report on Thursday, March 1st. TheStreet raised shares of Core Laboratories from a c rating to a b- rating in a research report on Thursday, February 1st. Finally, Royal Bank of Canada set a $125.00 target price on shares of Core Laboratories and gave the stock a buy rating in a research report on Tuesday, January 30th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $111.39.
Shares of Core Laboratories (NYSE:CLB) traded up $0.68 during midday trading on Thursday, reaching $106.06. 98,256 shares of the company traded hands, compared to its average volume of 465,593. Core Laboratories has a twelve month low of $86.55 and a twelve month high of $121.39. The company has a market cap of $4,767.10, a PE ratio of 56.05 and a beta of 1.47. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.66 and a current ratio of 1.98.
Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.58. Core Laboratories had a net margin of 12.60% and a return on equity of 58.25%. The firm had revenue of $172.00 million for the quarter, compared to analysts’ expectations of $171.92 million. During the same quarter last year, the firm earned $0.41 EPS. The company’s quarterly revenue was up 15.1% compared to the same quarter last year. equities analysts predict that Core Laboratories will post 2.7 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, February 16th. Investors of record on Friday, January 26th were issued a $0.55 dividend. The ex-dividend date was Thursday, January 25th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.07%. Core Laboratories’s dividend payout ratio (DPR) is presently 117.02%.
Several large investors have recently bought and sold shares of CLB. DF Dent & Co. Inc. bought a new stake in shares of Core Laboratories in the 4th quarter worth approximately $77,449,000. Bank of New York Mellon Corp raised its holdings in shares of Core Laboratories by 141.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 567,306 shares of the oil and gas company’s stock worth $55,992,000 after purchasing an additional 332,620 shares during the period. TimesSquare Capital Management LLC bought a new stake in shares of Core Laboratories in the 4th quarter worth approximately $32,005,000. Ameriprise Financial Inc. raised its holdings in shares of Core Laboratories by 1,087.6% in the 3rd quarter. Ameriprise Financial Inc. now owns 315,556 shares of the oil and gas company’s stock worth $31,143,000 after purchasing an additional 288,985 shares during the period. Finally, WCM Investment Management CA raised its holdings in shares of Core Laboratories by 5.5% in the 4th quarter. WCM Investment Management CA now owns 4,793,731 shares of the oil and gas company’s stock worth $525,153,000 after purchasing an additional 250,830 shares during the period.
TRADEMARK VIOLATION WARNING: This piece of content was first published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/03/16/core-laboratories-clb-coverage-initiated-by-analysts-at-credit-suisse-group.html.
About Core Laboratories
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.